Ozempic, originally developed for managing Type 2 diabetes, has gained widespread attention for its weight loss effects by slowing digestion and increasing feelings of fullness. While effective, a surprising side effect dubbed the “Ozempic vulva” is emerging. Social media users and some healthcare professionals report vaginal changes such as sagging labia, reduced muscle tone, and dryness. Though not officially recognized in medical literature, these symptoms appear to correlate with rapid fat and muscle loss, which can affect delicate pelvic tissues.

Doctors suggest several contributing factors: loss of fat in the pelvic area, dehydration, and hormonal fluctuations—all of which can result from Ozempic use. In response, some women are turning to cosmetic treatments like vaginal rejuvenation and dermal fillers to restore volume and tone, though these procedures are costly and carry risks.

While not all users experience these effects, the growing number of anecdotal reports highlights the need for more research. As use of weight-loss drugs increases, understanding their full impact—especially on under-discussed areas—is critical for informed healthcare decisions.